Markets › United States › NAS › ALNY

Alnylam Pharmaceuticals Inc

NAS:ALNYHealthcareNASDAQ:NBINASDAQ:NQUSMG

$233.29+0.63%At closeAt close · Tue 20 Oct · ≈ AED 856.76 · Market cap $31.22B · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	84.2%	83.4%	83.7%	83.0%	85.6%	81.8%	—	—
Operating margin	−168.1%	−83.9%	−75.7%	−15.4%	−7.9%	13.5%	13.5%	+0.0 pts
Net margin	−174.1%	−101.0%	−109.0%	−24.1%	−12.4%	8.4%	8.4%	+0.0 pts
EBITDA margin	−149.4%	−78.4%	−89.3%	−14.1%	−8.0%	17.0%	—	—
Return on equity	−84.5%	−145.0%	714.9%	199.5%	−414.6%	39.8%	39.8%	+0.0 pts
Return on assets	−25.2%	−23.4%	−31.9%	−11.5%	−6.6%	6.3%	6.3%	+0.0 pts
Return on capital employed	−29.4%	−24.0%	−28.3%	−9.9%	−5.8%	14.3%	—	—
Debt / equity	0.5×	1.7×	−8.3×	−5.9×	40.9×	1.6×	1.6×	+0.0%
Debt / assets	15.3%	27.4%	37.2%	34.1%	64.7%	25.7%	—	—
Interest coverage	−9.8×	−5.0×	−5.0×	−2.3×	−1.2×	2.0×	—	—
Current ratio	4.5×	4.0×	3.5×	3.1×	2.8×	2.8×	2.8×	+0.0%
Quick ratio	4.3×	3.9×	3.3×	3.0×	2.7×	2.7×	—	—
Cash ratio	0.8×	1.2×	1.1×	0.8×	0.8×	1.1×	1.1×	+0.0%
Asset turnover	0.1×	0.2×	0.3×	0.5×	0.5×	0.7×	—	—
Inventory turnover	1.0×	1.6×	1.3×	3.5×	4.1×	8.2×	—	—
Receivables turnover	0.8×	4.3×	4.4×	5.6×	5.5×	4.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—